Oxygenating the Pipeline

This evening event profiles the bench to bedside progress of the Cima Lab's efforts targeting tumor oxygen levels as a vulnerability in cancer. Through innovative prototyping and clinical trials, researchers have developed a responsive sensor to sample and relay information about oxygen levels that can inform treatment decisions to dramatically affect how tumors respond to radiation therapy. Discover the ins and outs of personalized treatment and learn how the team is drawing on resources across the research spectrum to improve cancer treatment and patient outcomes.

Featured Presenters

Michael Cima, PhD

David H. Koch (1962) Professor of Engineering
Professor of Materials Science and Engineering
Co-founder, Stratagen Bio

Gregory Ekchian, PhD

Co-founder and CEO, Stratagen Bio
Former Postdoctoral Fellow, Koch Institute at MIT

Robert Cormack, PhD

Physicist, Radiation Oncology, Brigham and Women's Hospital
Associate Professor, Radiation Oncology, Harvard Medical School

Presented as part of the Koch Institute's tenth anniversary celebrations.

Related News